Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Wall Street Journal: “Facing Criticism, Drug Makers Keep Lid On Price Increases"
February 26, 2017 Jonathan D. Rockoff and Peter Loftus Facing mounting criticism about prices, drug companies put some limits on their increases this year. Prescription-drug makers traditionally raise list prices in January. This year, they didn’t raise prices for as many drugs as last year and imposed fewer boosts of 10% or greater, according to […]
News and Reports
WBUR: “Not Just Nausea And Vomiting: Cancer Docs Now Worry About 'Financial Toxicity'"
February 24, 2017 Richard Knox Just imagine how it would feel: Your doctor diagnoses cancer. She says there’s a good chance you can beat it, or keep it under control for a long time. But you can’t afford the thousands of dollars you’d have to pay for treatment that your health insurer won’t cover. That […]
News and Reports
Reuters: “Many U.S. cancer patients struggle to afford life-saving medications"
February 22, 2017 Madeline Kennedy As cancer drug costs rise, U.S. cancer patients are more likely than other medical patients to struggle with paying for prescription medications, according to a recent study. The financial burdens are especially high for patients under age 65 who cannot access Medicare, the government insurance program for the elderly, and […]
News and Reports
Kaiser Health News: “Sky-High Prices For Orphan Drugs Slam American Families And Insurers”
January 17, 2017 Sarah Jane Tribble and Sydney Lupkin Before Luke Whitbeck began taking a $300,000-a-year drug, the 2-year-old’s health was inexplicably failing. A pale boy with enormous eyes, Luke frequently ran high fevers, tired easily and was skinny all over, except his belly stuck out like a bowling ball. “What does your medicine do […]
News and Reports
STAT News: “Behind patient advocacy groups, donors are exerting a powerful force, study says”
January 17, 2017 Sheila Kaplan WASHINGTON — At a time when drug company lobbyists are widely vilified as icons of avarice, patient advocacy groups still wear the white hats. But those organizations, which promote cures for every type of cancer and hundreds more diseases, have come under criticism lately for favoring their drug company funders […]
News and Reports
Washington Post: “Trump vows ‘insurance for everybody’ in Obamacare replacement plan”
January 15, 2017 Robert Costa and Amy Goldstein President-elect Donald Trump said in a weekend interview that he is nearing completion of a plan to replace President Obama’s signature health-care law with the goal of “insurance for everybody,” while also vowing to force drug companies to negotiate directly with the government on prices in Medicare […]
News and Reports
New York Times: “Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits”
December 19, 2016 Matt Richtel and Andrew Pollack Enthusiasm for cancer immunotherapy is soaring, and so is Arie Belldegrun’s fortune. Dr. Belldegrun, a physician, co-founded Kite Pharma, a company that could be the first to market next year with a highly anticipated new immunotherapy treatment. But even without a product, Dr. Belldegrun has struck gold. […]
News and Reports
US News: “The Harm of High Drug Prices”
December 12, 2016 Hagop Kantarjian and Vivian Ho The problem of high cancer drug prices in the United States was highlighted in 2013, following a decade during which the average annual price of newly introduced cancer drugs increased from less than $10,000 to more than $100,000 in 2012. In a for-profit health care industry, drug […]